AstraZeneca’s £450m Speke U-turn looks terrible for a pro-growth government

阿斯利康4.5亿英镑在斯佩克的逆转对支持经济增长的政府来说看起来非常糟糕

AstraZeneca has research operations in Cambridge, as well as the vaccine manufacturing plant at Speke, a suburb of Liverpool in Merseyside.

AstraZeneca has research operations in Cambridge, as well as the vaccine manufacturing plant at Speke, a suburb of Liverpool in Merseyside.

2025-02-04  719  中等
字体大小

There were additional reasons for the boosterish tone. Relations between the life sciences industry and the Tory government had been dire in the two years after the Covid pandemic. Companies grumbled about research and development tax credits, the NHS’s spending formula for prescription medicines and a post-Covid hangover in the health service’s ability to conduct clinical trials. The Speke deal seemed to signal a reset.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。